Transcription factors of the bHLH-PAS protein family are important regulators of developmental processes such as neurogenesis and tracheal development in invertebrates. Recently a bHLH-PAS protein, named trachealess (trl) was identified as a master regulator of tracheogenesis. Hypoxia-inducible factor, HIF-1a, is a vertebrate relative of trl which is likely to be involved in growth of blood vessels by the induction of vascular endothelial growth factor (VEGF) in response to hypoxia. In the present study we describe mRNA cloning and mRNA expression pattern of mouse HIF-related factor (HRF), a novel close relative of HIF-1a which is expressed most prominently in brain capillary endothelial cells and other blood vessels as well as in bronchial epithelium in the embryo and the adult. In addition, smooth muscle cells of the uterus, neurons, brown adipose tissue and various epithelial tissues express HRF mRNA as well. High expression levels of HRF mRNA in embryonic choroid plexus and kidney glomeruli, places where VEGF is highly expressed, suggest a role of this factor in VEGF gene activation similar to that of HIF-1a. Given the similarity between morphogenesis of the tracheal system and the vertebrate vascular system, the expression pattern of HRF in the vasculature and the bronchial tree raises the possibility that this family of transcription factors may be involved in tubulogenesis.
Introduction
Growth and differentiation of embryonic blood vessels comprise different processes such as the establishment of the endothelial cell lineage during early embryogenesis and the formation of the primary capillary plexus (vasculogenesis) , and the propagation of this plexus by proliferation, sprouting, intussusception and vascular remodelling (angiogenesis) (for review see Risau, 1995; Risau and Flamme, 1995) . Paracrine systems consisting of growth factors produced by the tissue to be vascularized and signal transducing receptors expressed on the endothelial cell have been implicated in angiogenesis. As a prototype of such a paracrine regulatory system the vascular endothelial growth factor VEGF and its high affinity receptor flk-1 (VEGFR-2) have been identified to be essential and sufficient for physiological as well as pathological neovascularization (Plate et al., 1994; Flamme et al., 1995;  for review see Ferrara et al., 1992; Breier and Risau, 1996) . VEGF itself is regulated by extrinsic factors, such as oxygen tension: hypoxia leads to an increase in VEGF mRNA expression (Shweiki et al., 1992; Ikeda et al., 1995; Liu et al., 1995) . Thus, the well known phenomenon of increased angiogenesis in response to hypoxia was put onto a molecular basis. Recently, as a link between hypoxia and transcriptional activation of the VEGF gene, the basic helix-loop-helix transcription factor HIF-1a was discovered which is a member of the PAS (Period, Aryl-hydrocarbon-receptor, Single minded)-protein family (Wang et al., 1995; Forsythe et al., 1996) . After heterodimerization with the Aryl-hydrocarbon-receptor-nuclear-translocator (ARNT), another member of the bHLH-PAS domain factor family, the dimer is translocated into the nucleus and binds to the hypoxia-responsive element, HRE (Wood et al., 1996) , a well characterized DNA motif present in many hypoxia-inducible genes. Hypoxia responsiveness of most of these genes is dependent on HIF-1a (for review see Semenza, 1996; Semenza et al., 1996) . Interestingly, the amino acid sequence of the basic domain of HIF-1a is identical to that of trachealess (trl), a bHLH-PAS protein recently cloned from Drosophila which is essential for the early development of the tracheal system and other branched tubular systems in the fly (Isaac and Andrew, 1996; Kuo et al., 1996; Wilk et al., 1996) . trl fulfills the requirements of a master regulator for the development of tracheocytes. Since the morphogenesis of the tracheal system of insects tightly resembles that of the vascular system of vertebrates forming a branched tubular network by sprouting, and since hypoxia of tissues is essential for both the tracheal and the vascular sprouting and invasion (Manning and Krasnow, 1993) , it was tempting to consider HIF-1a as a functional homologue of trl. However, HIF-1a is an extrinsic regulator of endothelial function acting via VEGF, whereas a true functional homologue of trl would be expected to act as a cell autonomous regulator of endothelial differentiation.
Such intrinsic differentiation factors are well known e.g. as potent inducers of the myogenic program (MyoD, Myogenin, Myf5, MRF4) (Weintraub et al., 1991; Lassar and Munsterberg, 1994 ), but they are as yet unidentified in the endothelial cell lineage. Candidate factors are supposed to be expressed by endothelial cells and their precursors very early during development when the endothelial cell lineage is established. They are thought to be instructive in the transcription of early essential endothelial-specific genes such as the receptor tyrosine kinases flk-1 and tie-2 (Sato et al., 1995; Shalaby et al., 1995) .
In view of the morphological relationship between the vascular system of vertebrates and the tracheal system of invertebrates and in order to identify factors which are possibly involved in early steps of vascular development, we performed a homology screen for trl-related factors in vertebrate endothelium. In the present study we describe cloning, mRNA sequence and expression pattern of a novel member of the bHLH-PAS protein family of transcription factors which is closely related to HIF-1a, and therefore was called HRF. HRF is expressed by endothelial cells in the brain and other organs and in the bronchial system during mouse embryogenesis as well as in the adult. The expression pattern raises the possibility that HRF is a new candidate for a regulator of tubulogenesis in vertebrates like trl in Drosophila.
Results

Cloning of HRF mRNA
In order to identify homologues of the bHLH-PAS domain proteins HIF-1a and trl expressed by endothelial cells, we screened a neonatal mouse brain capillary endothelial cell cDNA library (Schnürch and Risau, 1993) using a human expressed sequence tag (EST) clone (GenBank accession number T70415). In a gene bank database search this clone revealed significant homology to HIF-1a. It was purchased from the IMAGE consortium (Research Genetics, Inc. Huntsville, AL, USA). By DNA sequencing this clone was 811 bp in length and the predicted translation product included a putative PAS B domain. A total of 500 000 lgt10 phage clones were plated. More than 100 positive hybridization signals were obtained, 48 of which were further analyzed for their size using a lgt10 phagespecific pair of PCR primers for amplification of the insert DNA. Three clones of about 2.5, 3.0 and 3.5 kb were cloned into pBluescript and completely sequenced after subcloning (Fig. 1A) . All three clones contained the putative ATG start codon with the consensus sequence for translational initiation. While they started at about the same 5′ position (−75, −141, −183), they differed largely at the 3′ end. Two of them contained a putative open reading frame of 2622 bp. Translation of this open reading frame into amino acid sequence resulted in an 874 amino acid protein with high sequence homology to human HIF-1a with an overall homology of 45% (Fig. 1B) . Alignment with the HIF-1a amino acid sequence revealed that the bHLH and the PAS domains were highly conserved (83% and 73% of homology for PAS A and B domains, respectively) (Fig. 2) . Large differences existed in the C-terminal region ending in a high homology stretch of 49 amino acids at the extreme C-terminus (not shown). Thus, the last 83 amino acids of HIF-1a which are essential for stabilization of the protein during hypoxia were partly represented in the HRF sequence (Li et al., 1996) . In the core basic domain 11 out of 12 amino acids were conserved as compared with HIF-1a and trl, only at position 25 a cysteine was substituted for the serine of the HIF sequence. We further compared the bHLH and the PAS domain of HRF with those of Drosophila trl and the mouse homologue of Drosophila single minded (Fig. 2) . HRF was more closely related to Drosophila trl than to mouse single minded (mSIM) with homologies of 67% versus 58% for the bHLH and 46% versus 43% for the PAS A and B domains. Thus, HRF represents a novel HIF1a-related putative bHLH-PAS transcription factor.
Northern blot analysis, RT-PCR and in vitro translation
We then examined the expression profile of the HRF mRNA by means of Northern blot analysis of adult mouse tissues. The probe was derived from the 3′ end of the 2.5 kb clone (Hind III-Not I fragment) that did not display significant homology to HIF-1a on the nucleotide level (Fig. 1A) . Two major bands of 5200 nt and 5300 nt hybridized with this probe in all RNAs examined with the exception of spleen RNA where the smaller band was missing (Fig. 3) . Thus, no cross-hybridization with HIF-1a mRNA was observed which is about 4200 nt in length. The strongest hybridization signal was detected in lung RNA followed by heart, kidney, liver and brain. Minor amounts of HRF mRNA were detected in testis, skeletal muscle and spleen (Fig. 3) . In kidney RNA an additional band of about 2600 nt was observed. Since the longest cDNA clone we obtained was only 3.5 kb as compared to 5.2 knt of the mRNA determined by Northern blot analysis, it can be assumed that the cDNA clone does not encompass the entire untranslated regions, most probably due to lacking parts of the 3′ end.
By reverse transcription PCR HRF mRNA was detected in embryonic tissues such as lung, liver, heart, brain and kidney (not shown). We also examined a variety of human and murine cell lines for the expression of HRF mRNA. Abundant amounts of PCR product were obtained by amplifying cDNA from endothelial cells. However, lymphocyte cell lines, macrophages and several tumor cell lines also expressed HRF. Interestingly, human as well as murine 3T3 fibroblasts were the only cells that did not express detectable amounts of HRF mRNA (not shown).
Translation of the open reading frame of HRF predicts a protein of 874 amino acids with a molecular weight of 96 742 Da. This was substantiated by in vitro translation of the 3.5 kb cDNA clone after transcription into a sense RNA. After SDS PAGE and autoradiography, the 35 Smethionine-labeled translation product was detected at about 95 kDa (not shown).
In-situ hybridization
As we were interested in the role of HRF during development, we examined the expression pattern of its mRNA by means of in situ hybridization using 35 S-labeled antisense RNA probes in embryos and in the adult. In situ hybridization was performed with two probes generated from independent templates: a Pst I-Hind III fragment located just downstream of the sequence coding for the PAS B domain and a Sal I-Not I fragment located around the translation termination codon in the 3 kb clone (Fig. 1A) . Both sequences did not share significant homology with the HIF-1a mRNA sequence.
In E 7.5 and E 8.5 mouse embryos expression of HRF mRNA is ubiquitous in the embryo proper and the yolk sac when compared with the sense control ( Fig. 4A-C) . Strong expression was observed in the smooth muscle cells of the surrounding uterus (Fig. 4B ). At E11.5 HRF mRNA showed a more restricted expression pattern. Hybridization signals were observed in the walls of the dorsal aortae and the Fig. 2 . Alignment of the peptide sequences of the bHLH and PAS domains of mouse HIF-1a related factor (HRF), human hypoxia-inducible factor-1a (HIF1a), mouse single minded (mSIM), and Drosophila trachealess (trl). Homology domains are depicted by different colors: orange, core basic domain; blue, helix-loop-helix-domain; purple, internal homology domains PAS A and PAS B.
cardinal veins but not in the adjacent gut epithelium (Fig.  4D) . The signal could be localized to endothelial cells as well as to surrounding cells, most likely representing smooth muscle cells of the vessel wall. In the perineural capillary plexus the hybridization signal was located on endothelial cells of capillaries (Fig. 4E ). In addition, HRF signal was observed on neuroectodermal cells of the brain and spinal cord (Fig. 4E) , on dorsal root ganglia and on somites (not shown). At E15.5 expression of HRF was detected on endothelial cells of the brain (Fig. 4F,G) , the skin (not shown), and the kidney (Fig. 4I) . In sagittal sections of the brain the streaky hybridization signals on capillary endothelial cells gave the impression of the radial orientation of blood vessels growing perpendicularly from the perineural plexus into the neuroectoderm (Fig. 4F,G) . In the choroid plexus (Fig. 4H) , and in kidney glomeruli (Fig.  4I ) HRF is expressed by both epithelial and endothelial cells. Also, in other non-endothelial cells remarkable amounts of HRF mRNA could be detected: in neurons of the brain, in the brown adipose tissue of the neck (Fig. 4K) , in the respiratory epithelium of the nose (Fig. 4L ) and in the bronchial epithelium of the lung (Fig. 4M) . Also, in muscles, liver parenchyma, epidermis and the thyroid gland expression of HRF was observed (not shown). In the adult mouse HRF mRNA was detected in the brain in both neuronal layers and capillaries (Fig. 5A,B) . In the spleen, HRF mRNA was most prominent on the central arteries of the white pulpa and less abundant on the surrounding lymphocytes (Fig. 5C ). In the adult lung strong hybridization was located in respiratory epithelium of the bronchi, but to much lower levels in endothelium of large vessels (Fig. 5D,E) . It was unclear if the signal in the lung parenchyma was due to mRNA expression by pneumocytes or by capillary endothelial cells. However, the strong hybridization signal is consistent with the result obtained by Northern hybridization. In the kidney, diffuse hybridization was present but no distinct hybridization signal could be detected in the glomeruli. Also, in the liver, heart and skeletal muscle hybridization was diffuse in the parenchyma and no distinct signal was visible on endothelium (Fig. 5F ). Thus, HRF mRNA was detected in endothelial cells, but also in many other cells such as smooth muscle cells, epithelial cells and neurons. With the exception of brain capillaries and central arteries of the spleen, vascular endothelium of the adult obviously does not express similar high levels of HRF mRNA as embryonic endothelium.
Discussion
In the present study we describe cDNA cloning and mRNA expression pattern of a novel bHLH-PAS domain protein with high homology to the transcriptional regulator HIF-1a (Wang et al., 1995) . Therefore, the new putative transcription factor was termed HIF-1a related factor, HRF. HRF was cloned from a brain capillary endothelial cell cDNA library in which its mRNA was highly represented. This high representation in a brain endothelial cell library is in line with the expression pattern in vivo: HRF mRNA is highly expressed by brain capillary endothelial cells in the embryo and the adult but also in other vascular beds such as kidney glomeruli, choroid plexus and spleen arteries. However, expression of HRF was not found to be restricted to the endothelium: smooth muscle cells, epithelia and neurons also had detectable amounts of HRF mRNA. By its distinct expression pattern HRF is distinguished from its close relative HIF-1a and its binding partner ARNT which show a more widespread expression (Abbott and Probst, 1995; Wenger et al., 1996; Wiener et al., 1996) . Binding of HIF-1a to ARNT has been shown to be essential for the translocation of the factor from the cytosol to the nucleus where the HIF-1a/ARNT heterodimer acts as a transcriptional activator of hypoxia-sensitive genes (Semenza, 1996) . Since the interaction of HIF-1a with ARNT is mediated by the PAS domains and since other less related PAS proteins have been shown to interact with ARNT in the same way as HIF-1a, it is possible that HRF also interacts with ARNT to become an active tran- scriptional regulator. As far as the expression of HRF in the brain and kidney is concerned, there is at least one other possible interaction partner, the recently cloned ARNT-2 which is highly expressed in brain and kidney but not in other organs . In neurons, another bHLH-PAS domain transcription factor, the vertebrate homologue of Drosophila single minded , probably exerts essential functions during brain development. It is conceivable that vertebrate SIM and HRF in neurons represent a redundant system of transcriptional regulators, since vertebrate SIM has been shown to interact with ARNT and ARNT 2 .
The expression pattern of HRF mRNA is suggestive of a role of the factor during tubulogenesis: HRF mRNA is expressed in embryonic endothelium and respiratory epithelium of the bronchi. As a possible binding partner ARNT was localized in branching lung epithelium (Abbott and Probst, 1995) . Both systems, the vasculature and the bronchial tree, grow by branching and sprouting, thus propagating a tubular network of endothelial/epithelial cells into a solid tissue. Tubular networks which are propagated by branching and sprouting of terminal cells are also known from invertebrates, such as the tracheal system in insects which closely resembles the vascular system of vertebrates as far as its morphogenesis is concerned (Manning and Krasnow, 1993) . In Drosophila the bHLH-PAS domain protein trachealess (trl) was identified as a master regulator of tracheogenesis (Isaac and Andrew, 1996; Wilk et al., 1996) . Interestingly, the amino acid sequence of the DNA binding basic domain is identical to that of HIF-1a. Furthermore, tracheae and blood vessels grow in response to hypoxia, and in response to hypoxia HIF-1a is thought to mediate the transcriptional activation of the vascular endothelial growth factor (VEGF) gene (Forsythe et al., 1996) which is the major regulator of blood vessel growth during physiological and pathological angiogenesis (for review see Breier and Risau, 1996) . During early ontogeny, the VEGF-VEGFreceptor signalling system was demonstrated to be essential for the establishment of the endothelial cell lineage and the primitive vascular plexus (Fong et al., 1995; Shalaby et al., 1995; Carmeliet et al., 1996; Ferrara et al., 1996) . Thus, it was tempting to assume that HIF-1a is a functional homologue of trl concerning the establishment and tubulogenesis of the vascular network. However, trl is a tracheocyte cell autonomous regulator of morphogenesis, whereas the activation of VEGF gene transcription via HIF-1a in response to hypoxia is a paracrine (extrinsic) mechanism, e.g. VEGF is released by the tissue to be vascularized and binds to its signal transducing receptor flk-1 on the invading endothelial cell (Millauer et al., 1993) . Unlike HIF-1a, its novel homologue HRF is highly expressed in the endothelium itself and is therefore a better candidate for such a cell autonomous regulator of cell type differentiation. To date, master regulators have been identified for the myoblast lineage (for review see Weintraub et al., 1991; Lassar and Munsterberg, 1994) and hematopoietic cells (for review see Shivdasani and Orkin, 1996) in particular, and the mesodermal (Quertermous et al., 1994; Blanar et al., 1995; Burgess et al., 1995; Saga et al., 1996) and neuroectodermal cell fate decision in general (Lee et al., 1995; Ma et al., 1996) . It is still missing for the endothelial cell lineage, although this is one of the first lineages to be determined in the early mesoderm and endothelial cells are highly abundant in the early embryo. It was suggested that the c-ets transcription factor is involved in the early differentiation step from a pluripotent precursor towards the endothelial cell (Pardanaud and Dieterlen-Lievre, 1993) as well as in angiogenesis (Wernert et al., 1992) . However, direct evidence is still missing. Since HRF mRNA is expressed ubiquitously in early embryos at the stage of endothelial differentiation, the candidate function of an early endothelial differentiation factor cannot necessarily be attributed to HRF. However, mRNA expression of a transcription factor in a certain subset of cells does not necessarily mean that this factor is active as a protein.
The most valuable information about the role of HRF in vascular development may be provided by future immunocytochemical localization of the active protein in the nuclei of angioblastic and endothelial cells.
At present it can only be speculated whether HRF, supposing that it acts as a transcriptional regulator, binds to the same DNA motif as HIF-1a because there is one amino acid exchanged in the basic domain. Furthermore, it is questionable whether HRF, like HIF-1a, is regulated by oxygen tension, because it has recently been shown that HIF-1a protein is stabilized by hypoxia and that this stabilization depends on carboxyterminal sequences which are variable between HIF-1a and HRF (Huang et al., 1996; Li et al., 1996) . The transactivation properties of HIF-1a also reside in the carboxyterminal sequence Li et al., 1996) . Thus, differences in the transactivation properties between the two related factors are likely to exist.
Apart from HRF expression in the endothelium, it correlates with the expression of VEGF (Breier et al., 1995) which is a target gene for HIF-1a under hypoxia. Like VEGF, HRF is highly expressed in the kidney glomeruli, in the choroid plexus, and in the brown adipose tissue in the embryo as well as in the liver and the lung parenchyma. In contrast to VEGF, in the embryonic kidney and choroid plexus HRF is highly expressed not only in the epithelial, but also in the endothelial cells where VEGF receptors are present at high levels at this stage of development (Breier et al., 1995; Millauer et al., 1993) .
Further experiments using VEGF promoter-reporter gene constructs will answer the question whether HRF is a constitutive or hypoxia-inducible activator of VEGF gene transcription. Thus, HRF is a candidate for both an intrinsic and extrinsic regulator of endothelial function, which might be under the control of metabolic demands. Depending on the cell type in which HRF is expressed, the factor may be integrated in different signal transduction pathways leading to activation of different cell type-specific target genes. In the endothelium, such genes are the receptor tyrosine kinases flk-1 and tie-2 (Millauer et al., 1993; Sato et al., 1995) . Unlike HRF, their expression levels in brain capillaries remarkably decrease after birth (Millauer et al., 1993; Schnürch and Risau, 1993) . Future work will reveal if HRF is integrated in the network of signal transduction systems that regulate the differentiation of the vascular system in vertebrates.
Experimental procedures
Cloning of HRF cDNA
A total of 5 × 10 5 clones of a P4 -P8 mouse brain capillary endothelial cell cDNA library in the phage vector lgt10 (described in Schnürch and Risau, 1993) were plated and hybridized with a 32 P-dCTP-labeled double stranded cDNA probe generated by random primed labelling of the human EST cDNA clone with the GenBank accession number T70415 (purchased from the IMAGE consortium, Research Genetics, Inc. Huntsville, AL, USA; clone order number 67043). The inserts of hybridizing clones were amplified by PCR using the lgt10-specific PCR primers 5′-GCG-AATTCGCTTATGAGTATTTCTTCCAGG-3′ (5′ oligonucleotide) and 5′-GCGAATTCAGCAAGTTCAGCCTG-GTTAAG-3′ (3′ oligonucleotide) located just upstream and downstream of the EcoRI cloning site of lgt10. PCR conditions were 40 cycles, 20 s at 94°C, 30 s 65°C and 2 min 68°C using Klentaq (Clontech, Palo Alto, CA, USA) instead of Taq-DNA-Polymerase. Since cDNA was cloned into the EcoR I site of the lgt10 vector after blunt end ligation to EcoR I-Not I Adaptors (Pharmacia), the amplified inserts from the PCR reactions were digested with Not I and ligated into the Not I site of pBluescript (Stratagene) after purification on Qiaquick (Qiagen) spin columns. Three overlapping clones of about 2.5, 3, and 3.5 kb were sequenced on an Applied Biosystems DNA sequencer after subcloning of overlapping restriction fragments into pBluescript.
Northern blot analysis and RT-PCR
RNA preparation and Northern Blot analysis of total RNA from mouse tissues were performed as described previously . In addition, a mouse multiple tissue Northern Blot (2 mg PolyA + RNA per lane) was hybridized according to the instructions of the manufacturer (Clontech, Palo Alto, CA, USA). A double stranded 32 PdCTP-labeled probe was generated from a Hind III-Not I fragment of the 2.5 kb HRF cDNA clone (Fig. 1) using random priming and Klenow fragment of DNA polymerase I. Hybridization was performed in the presence of 2 × 10 6 cpm/ml radiolabeled probe in hybridization buffer at 68°C. The membranes were washed twice in 2 × SSC, 0.1% SDS, and twice in 0.1 × SSC, 0.1% SDS at 50°C. Membranes were exposed to Kodak X-OMAT films. As a loading control a second hybridization was performed with a human b-actin probe.
RT-PCR was performed essentially as described by Tan and Weis (1992) . Five to 10 mg of total RNA was reverse transcribed in a 20 ml reaction volume for 1 h at 37°C using the MMLV reverse transcriptase (Gibco-BRL) as described by the manufacturer. Aliquots of 1 ml of the reaction product were subjected to 40 rounds of amplification in a 20 ml reaction volume using a PCR reagent kit (Promega) and a temperature cycler (Perkin-Elmer Cetus). Cycles were 30 s at 94°C, 30 s 67°C and 30 s 72°C. The nucleotide sequences of the primers were deduced from the EST clone sequence mentioned above: 5′-AGCACCCATCCCACATGGACA-TC-3′ (5′ oligonucleotide) and 5′-CAGGGAATCAAATC-CTGGTCCCAA-3′ (3′ oligonucleotide). PCR products were analyzed by Southern blot analysis using a 32 P-labeled HRF probe.
In vitro translation
HRF cDNA clones in pBluescript KS + were transcribed into sense RNA using T3 RNA polymerase and the transcript was translated into protein in the presence of [ 35 S]methionin. The reactions were performed as one tube reaction using the TNT Coupled Reticulocyte Lysate Systems (Promega, Madison, WI, USA). Aliquots of the reactions were separated on SDS polyacrylamide gels after denaturation. Gels were dried and exposed to Kodak X-OMAT films.
In situ hybridization
In situ hybridizations were performed essentially as described previously . Briefly, embryos and adult mouse tissues were fixed in freshly prepared 4% paraformaldehyde in PBS for 30 min to 3 h. After dehydration in a series of graded ethanol, the specimens were embedded in Paraplast ® using xylene as intermedium.
Serial sections of 8 mm were collected on silanized slides. Paraffin was removed from the sections with xylene, sections were washed in 100% ethanol and then air-dried. Sections were digested in 0.2 N HCl for 20 min, washed in H 2 O followed by digestion in Pronase (1.25 mg/ml) for 10 min at room temperature. The digestion was stopped in 0.2% glycine. Slides were rinsed in PBS, postfixed in 4% paraformaldehyde and rinsed again with PBS. Sections were acetylated with acetic anhydride diluted 1:400 in 0.1 M triethanolamine (pH 8) for 10 min and then washed in PBS. Sections were dehydrated through ethanol and then air-dried. Single stranded sense and antisense 35 S-RNA probes were generated by in vitro transcription of HRF subclones (using 100 mCi [ 35 S]UTP and T3 or T7 RNA polymerase essentially as described by the manufacturer (Stratagene)). RNA probes were purified using Qiaquick spin columns, dissolved in 50% formamide, 10 mM DTT and stored at −80°C. Hybridization was performed at 48°C overnight in 20 ml hybridization buffer (50% formamide, 10% dextran sulfate, 10 mM Tris-HCl pH 7.5, 10 mM sodium phosphate pH 6.8, 5 mM EDTA, 150 mg/ml E. coli tRNA, 0.1 mM UTP, 1 mM ADPbS, 10 mM gS-ATP, 1 mM DTT, 1 mM 2-mercapto-ethanol) supplemented with 5 × 10 4 cpm labeled RNA probe per section. Slides were rinsed in wash buffer (2 × SSC, 50% formamide, 10 mM 2-mercapto-ethanol) at 37°C for 2 h followed by RNase digestion (20 mg/ml) for 15 min at 37°C. Slides were further rinsed with wash buffer overnight at 37°C, dehydrated through ethanol and dried. Slides were coated with Kodak NTB-2 emulsion diluted 1:1 with H 2 O and exposed for 2-3 weeks. Slides were developed in Kodak D-19 developer and counterstained with Giemsa's staining solution (Merck).
Note added in proof
During submission of this manuscript, a very similar sequence, called EPAS-1, was published by Tian and colleagues (Genes & Development 11: 72-82).
